Literature DB >> 15903253

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.

Jamal Meghrous1, Marc G Aucoin, Danielle Jacob, Parminder S Chahal, Normand Arcand, Amine A Kamen.   

Abstract

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell system at various scales is presented. Shake flask studies were conducted to assess conditions to be used in bioreactors. Two insect cell lines, Trichoplusia ni (H5) and Spodoptera frugiperda (Sf9), were compared for their ability to produce rAAV-2 after infection with recombinant baculoviruses coding for the essential components of the vector. The effect of varying the ratio between individual baculoviruses and the effect of the overall multiplicity of infection (MOI), as well as the cell density at infection, were also examined. Infectious rAAV-2 particles were proportionally produced when increasing the individual MOI of BacRep virus up to 1.6. When equal amounts of each virus were used, a leveling effect occurred beyond an overall MOI of 5 and a maximum titer was obtained. Increasing the cell density at infection resulted in higher yields when infecting the cells in fresh medium; however, for the production of bioactive particles, an optimal peak cell density of approximately 1 x 10(6) cells/mL was observed without medium exchange. Infection in 3- and 20-L bioreactors was done at an overall MOI of 5 with a ratio of the three baculoviruses equal to 1:1:1. Under these conditions and infecting the cells in fresh medium, a total of approximately 2.2 x 10(12) infectious viral particles (bioactive particles) or 2.6 x 10(15) viral particles were produced in a 3-L bioreactor. Without replacing the medium at infection, similar titers were produced in 20 L. Our data demonstrates the feasibility of rAAV-2 production by BEVS at various scales in bioreactors and indicates that further optimization is required for production at high cell densities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15903253     DOI: 10.1021/bp049802e

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  16 in total

1.  A versatile adeno-associated virus vector producer cell line method for scalable vector production of different serotypes.

Authors:  Zhenhua Yuan; Chunping Qiao; Peiqi Hu; Juan Li; Xiao Xiao
Journal:  Hum Gene Ther       Date:  2011-03-18       Impact factor: 5.695

2.  Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system.

Authors:  Erik Kohlbrenner; George Aslanidi; Kevin Nash; Stanislav Shklyaev; Martha Campbell-Thompson; Barry J Byrne; Richard O Snyder; Nicholas Muzyczka; Kenneth H Warrington; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2005-10-06       Impact factor: 11.454

3.  Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells.

Authors:  Masashi Urabe; Takayo Nakakura; Ke-Qin Xin; Yoko Obara; Hiroaki Mizukami; Akihiro Kume; Robert M Kotin; Keiya Ozawa
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

5.  A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.

Authors:  Richard H Smith; Justin R Levy; Robert M Kotin
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

6.  Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.

Authors:  Ke-Qin Xin; Hiroaki Mizukami; Masashi Urabe; Yoshihiko Toda; Kaori Shinoda; Atsushi Yoshida; Kenji Oomura; Yoshitsugu Kojima; Motohide Ichino; Dennis Klinman; Keiya Ozawa; Kenji Okuda
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

8.  A Versatile Nonviral Delivery System for Multiplex Gene-Editing in the Liver.

Authors:  Jing Gong; Hong-Xia Wang; Yeh-Hsing Lao; Hanze Hu; Naazanene Vatan; Jonathan Guo; Tzu-Chieh Ho; Dantong Huang; Mingqiang Li; Dan Shao; Kam W Leong
Journal:  Adv Mater       Date:  2020-10-14       Impact factor: 30.849

Review 9.  Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.

Authors:  Alejandro Negrete; Robert M Kotin
Journal:  Brief Funct Genomic Proteomic       Date:  2008-07-16

10.  Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales.

Authors:  Alejandro Negrete; Robert M Kotin
Journal:  J Virol Methods       Date:  2007-07-02       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.